Cite
HARVARD Citation
Zhang, W. et al. (2018). Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer. Medicine. 97 (16), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, W. et al. (2018). Gefitinib provides similar effectiveness and improved safety than erlotinib for advanced non-small cell lung cancer. Medicine. 97 (16), p. . [Online].